In 2019 the NEUROLITH^® shock wave system was successfully introduced to the market. The Transcranial Pulse Stimulation (TPS^®) device, which was developed by STORZ MEDICAL in Switzerland, is the only medical device marketed in Europe that is approved in the European Union for the treatment of the central nervous system of patients with Alzheimer's disease. The effect of TPS^® is now being investigated in another neurological condition: In September 2020, the world's first clinical study for the treatment of Parkinson's patients with shock wave therapy using real-time documentation started at MedUni Vienna (Department of Neurology) in Austria under the direction of Professor Roland Beisteiner.

On 25 September 2020, Dr Marie-Claire Rassweiler-Seyfried (University Hospital Mannheim, Department of Urology and Urosurgery, Mannheim/Germany) received the »Christian Chaussy Award 2020« for her research* on electrohydraulic high-frequency ESWL. Her research focus was the evaluation of kidney damage.

In this live webinar Dr Alexander Sahi will talk about Low-intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for urological disorders.

In our first STORZ MEDICAL live webinar after the summer break Prof. Dr Karsten Knobloch will talk about the beneficial effects of ESWT in hand surgery.

A further milestone was reached on Monday. The ground-breaking ceremony and thus the start of construction of the new company building of STORZ MEDICAL Deutschland GmbH took place on 3rd August. In times of the corona crisis but in a modest setting and with only two protagonists. So architect and site manager, symbolically grabbed the shovel while the excavator waited in the background.